Literature DB >> 20511612

Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis.

Lijana Krause1, Mike O Becker, Claudia S Brueckner, Christina-Julia Bellinghausen, Corinna Becker, Udo Schneider, Thomas Haeupl, Katharina Hanke, Karin Hensel-Wiegel, Heidrun Ebert, Sabine Ziemer, Ulf-Müller Ladner, Matthias Pirlich, Gerd R Burmester, Gabriela Riemekasten.   

Abstract

OBJECTIVE: To assess and analyse nutritional status in patients with systemic sclerosis (SSc) and identify possible associations with clinical symptoms and its prognostic value.
METHODS: Body mass index (BMI) and parameters of bioelectrical impedance analysis (BIA) were assessed in 124 patients with SSc and 295 healthy donors and matched for sex, age and BMI for comparisons. In patients with SSc, BMI and BIA values were compared with clinical symptoms in a cross-sectional study. In a prospective open analysis, survival and changes in the nutritional status and energy uptake induced by nutritional treatment were evaluated.
RESULTS: Patients with SSc had reduced phase angle (PhA) values, body cell mass (BCM), percentages of cells, increased extracellular mass (ECM) and ECM/BCM values compared with healthy donors. Malnutrition was best reflected by the PhA values. Of the patients with SSc, 69 (55.7%) had malnutrition that was associated with severe disease and activity. As assessed by multivariate analysis, low predicted forced vital capacity and high N-terminal(NT)-proBNP values discriminated best between good and bad nutritional status. Among different clinical parameters, low PhA values were the best predictors for SSc-related mortality. BMI values were not related to disease symptoms or mortality. Fifty per cent of patients with SSc had a lower energy uptake related to their energy requirement, 19.8% related to their basal metabolism. Nutritional treatment improved the patients' nutritional status.
CONCLUSIONS: In patients with SSc, malnutrition is common and not identified by BMI. BIA parameters reflect disease severity and provide best predictors for patient survival. Therefore, an assessment of nutritional status should be performed in patients with SSc.

Entities:  

Mesh:

Year:  2010        PMID: 20511612     DOI: 10.1136/ard.2009.123273

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  23 in total

Review 1.  Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis.

Authors:  S Kumar; J Singh; S Rattan; A J DiMarino; S Cohen; S A Jimenez
Journal:  Aliment Pharmacol Ther       Date:  2017-02-09       Impact factor: 8.171

2.  Malnutrition, associated clinical factors, and depression in systemic sclerosis: a cross-sectional study.

Authors:  İpek Türk; Nihan Cüzdan; Volkan Çiftçi; Didem Arslan; Muharrem Cem Doğan; İlker Unal
Journal:  Clin Rheumatol       Date:  2019-05-26       Impact factor: 2.980

3.  Phase angle in systemic sclerosis: a marker for pulmonary function and disease severity.

Authors:  Antonietta Gigante; Maria Ludovica Gasperini; Andrea Iacolare; Danilo Alunni Fegatelli; Annalisa Villa; Maurizio Muscaritoli; Edoardo Rosato
Journal:  Clin Rheumatol       Date:  2020-03-13       Impact factor: 2.980

4.  Validation of Serbian version of UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument in 104 patients with systemic sclerosis.

Authors:  Ana Zekovic; Nemanja Damjanov
Journal:  Rheumatol Int       Date:  2017-03-07       Impact factor: 2.631

5.  Relationship between body composition and both cardiovascular risk factors and lung function in systemic sclerosis.

Authors:  Paola Caramaschi; Domenico Biasi; Cristian Caimmi; Giovanni Barausse; Davide Gatti; Marcello Ferrari; Sara Pieropan; Dania Sabbagh; Silvano Adami
Journal:  Clin Rheumatol       Date:  2013-09-20       Impact factor: 2.980

Review 6.  Gastrointestinal and Hepatic Disease in Systemic Sclerosis.

Authors:  Tracy M Frech; Diane Mar
Journal:  Rheum Dis Clin North Am       Date:  2018-02       Impact factor: 2.670

Review 7.  Gastrointestinal manifestations of scleroderma: recent progress in evaluation, pathogenesis, and management.

Authors:  Genevieve Gyger; Murray Baron
Journal:  Curr Rheumatol Rep       Date:  2012-02       Impact factor: 4.592

Review 8.  Intestinal Involvement in Systemic Sclerosis: A Clinical Review.

Authors:  Lazaros I Sakkas; Theodora Simopoulou; Dimitrios Daoussis; Stamatis-Nick Liossis; Spyros Potamianos
Journal:  Dig Dis Sci       Date:  2018-02-21       Impact factor: 3.199

9.  Clinical Assessment of Gastrointestinal Involvement in Patients with Systemic Sclerosis.

Authors:  Timothy Kaniecki; Tsion Abdi; Zsuzsanna H McMahan
Journal:  Med Res Arch       Date:  2020-10-29

Review 10.  Determinants of mortality in systemic sclerosis: a focused review.

Authors:  Dilli Ram Poudel; Divya Jayakumar; Abhijeet Danve; Shiv Tej Sehra; Chris T Derk
Journal:  Rheumatol Int       Date:  2017-11-07       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.